Skip to main content

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Alba Maria Jiménez Masip

Alba Maria Jiménez Masip

Predoctoral researcher
Liver Diseases
Read more
Carmen Pilar Simeón i Aznar

Carmen Pilar Simeón i Aznar

Main researcher
Systemic Diseases
Read more
Marta Fernandez Lobera

Marta Fernandez Lobera

Research technician
Research Group of Physical Medicine and Rehabilitation
Read more
Zaira Ivette Castañeda Amado

Zaira Ivette Castañeda Amado

Predoctoral researcher
Nephrology and kidney transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.